Glycobiology, 2001, Vol. 11, No. 6 459-471
© 2001 Oxford University Press
In vivo glycosylation of mucin tandem repeats
2Paediatric Molecular Genetics, Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK, 3Department of Biochemistry, Imperial College of Science, Technology and Medicine, South Kensington, London SW7 2AZ, UK, 4Eppley Institute, University of Nebraska Medical Center, Omaha NE, 68198-6805, USA, and 5Department of Biochemistry, University of Nebraska Medical Center, Omaha NE, 68198-6805, USA
The biochemical and biophysical properties of mucins are largely determined by extensive O-glycosylation of serine- and threonine-rich tandem repeat (TR) domains. In a number of human diseases aberrant O-glycosylation is associated with variations in the properties of the cell surfaceassociated and secreted mucins. To evaluate in vivo the O-glycosylation of mucin TR domains, we generated recombinant chimeric mucins with TR sequences from MUC2, MUC4, MUC5AC, or MUC5B, which were substituted for the native TRs of epitope-tagged MUC1 protein (MUC1F). These hybrid mucins were extensively O-glycosylated and showed the expected association with the cell surface and release into culture media. The presence of different TR domains within the chimeric mucins appears to have limited influence on their posttranslational processing. Alterations in glycosylation were detailed by fast atom bombardment mass spectrometry and reactivity with antibodies against particular blood-group and tumor-associated carbohydrate antigens. Future applications of these chimeras will include investigations of mucin posttranslational modification in the context of disease.
1 To whom correspondence should be addressed
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. K. Singh, Y. Wen, B. J. Swanson, K. Shanmugam, A. Kazlauskas, R. L. Cerny, S. J. Gendler, and M. A. Hollingsworth Platelet-Derived Growth Factor Receptor {beta}-Mediated Phosphorylation of MUC1 Enhances Invasiveness in Pancreatic Adenocarcinoma Cells Cancer Res., June 1, 2007; 67(11): 5201 - 5210. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Round, T. J. McMaster, M. J. Miles, A. P. Corfield, and M. Berry The isolated MUC5AC gene product from human ocular mucin displays intramolecular conformational heterogeneity Glycobiology, June 1, 2007; 17(6): 578 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Parry, F. G. Hanisch, S.-H. Leir, M. Sutton-Smith, H. R. Morris, A. Dell, and A. Harris N-Glycosylation of the MUC1 mucin in epithelial cells and secretions Glycobiology, July 1, 2006; 16(7): 623 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xia, J. A. Royall, G. Damera, G. P. Sachdev, and R. D. Cummings Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis Glycobiology, August 1, 2005; 15(8): 747 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Leir, S. Parry, T. Palmai-Pallag, J. Evans, H. R. Morris, A. Dell, and A. Harris Mucin Glycosylation and Sulphation in Airway Epithelial Cells Is Not Influenced by Cystic Fibrosis Transmembrane Conductance Regulator Expression Am. J. Respir. Cell Mol. Biol., May 1, 2005; 32(5): 453 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Santos-Silva, A. Fonseca, T. Caffrey, F. Carvalho, P. Mesquita, C. Reis, R. Almeida, L. David, and M. A. Hollingsworth Thomsen-Friedenreich antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism Glycobiology, May 1, 2005; 15(5): 511 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Cullen, W. Sabbagh Jr., E. Graham, M. M. Irick, E. K. van Olden, C. Neal, J. Delrow, L. Bardwell, and G. F. Sprague Jr. A signaling mucin at the head of the Cdc42- and MAPK-dependent filamentous growth pathway in yeast Genes & Dev., July 15, 2004; 18(14): 1695 - 1708. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Berry, R B Ellingham, and A P Corfield Human preocular mucins reflect changes in surface physiology Br J Ophthalmol, March 1, 2004; 88(3): 377 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wen, T. C. Caffrey, M. J. Wheelock, K. R. Johnson, and M. A. Hollingsworth Nuclear Association of the Cytoplasmic Tail of MUC1 and {beta}-Catenin J. Biol. Chem., September 26, 2003; 278(39): 38029 - 38039. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Silverman, M. Sutton-Smith, K. McDermott, P. Heal, S.-H. Leir, H. R. Morris, M. A. Hollingsworth, A. Dell, and A. Harris The contribution of tandem repeat number to the O-glycosylation of mucins Glycobiology, April 1, 2003; 13(4): 265 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Lofling, E. Hauzenberger, and J. Holgersson Absorption of anti-blood group A antibodies on P-selectin glycoprotein ligand-1/immunoglobulin chimeras carrying blood group A determinants: core saccharide chain specificity of the Se and H gene encoded {alpha}1,2 fucosyltransferases in different host cells Glycobiology, March 1, 2002; 12(3): 173 - 182. [Abstract] [Full Text] [PDF] |
||||





